Celontin

Active Ingredient(s): Methsuximide
FDA Approved: * February 8, 1957
Pharm Company: * PARKE DAVIS
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Celontin Overview

Mesuximide (or methsuximide, methosuximide) is a succinimide anticonvulsant medication. It is sold as a racemate by Pfizer under the tradenames Petinutin (Switzerland)[1] and Celontin (United States).[2] The therapeutic efficacy of methosuximide is largely due to its pharmacologically active metabolite, N-desmethylmethosuximide, which has a longer half-life and attains much higher plasma levels than its parent.[3] Medical use is indicated for...

Read more Celontin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mesuximide

Recent Celontin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Methsuximide
  • Capsule: 150mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Celontin: (2 results)

Sorted by National Drug Code
  • 0071-0525 Celontin 300 mg Oral Capsule by Parke-davis Div of Pfizer Inc
  • 24822-525 Celontin 300 mg Oral Capsule by Farmea

Other drugs which contain Methsuximide or a similar ingredient: (1 result)